FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022300629> ?p ?o ?g. }

• W2022300629 endingPage "76" @default.
• W2022300629 startingPage "67" @default.
• W2022300629 abstract "This study investigated whether baseline status could predict the responsiveness to one-year growth hormone (GH) replacement therapy in adult GH deficient (GHD) patients. A total of 380 European patients with adult onset GHD due to non-functioning pituitary adenoma that had been enrolled in Pfizer International Metabolic Database (KIMS), and that had completed one year of GH replacement therapy within KIMS, were studied. The mean initial dose of GH was 0.22 (SEM 0.01) mg/day and after one year, the mean dose was 0.36 (0.01) mg/day. The mean insulin-like growth factor-I (IGF-I) SD score increased from −1.75 (0.08) at baseline to 0.47 (0.05) after one year. Quality of life (QoL)-Assessment of GHD in Adults (QoL-AGHDA), waist circumference, waist:hip ratio, and serum lipid pattern improved. Women received a higher dose of GH than men after one year, and demonstrated similar treatment response. In multiple stepwise forward regression analyses, the one-year changes in QoL-AGHDA score, waist:hip ratio, and serum low density lipoprotein-cholesterol (LDL-C) level correlated inversely with the baseline values of the same variable. In addition, the change after one year in QoL-AGHDA score correlated inversely with duration of hypopituitarism and baseline serum high density lipoprotein-cholesterol (HDL-C) level, and the change in waist:hip ratio correlated inversely, although more weakly, with baseline serum HDL-C level and UK citizenship and positively with baseline waist circumference and the initial GH dose. The change in serum LDL-C level additionally correlated inversely with the mean GH dose and duration of hypopituitarism and positively with UK citizenship. Baseline status could, with moderate strength, predict the responsiveness in the same variable whereas it could not, or only weakly, predict the response in other variables. Therefore, when the decision to start GH replacement is undertaken, as many outcome variables as possible should be evaluated in order to adequately evaluate the likelihood of clinical benefit. Finally, women have a similar response to GH replacement as men when individualised GH dosing schedules are employed and should therefore be selected for GH therapy to a similar extent." @default.
• W2022300629 created "2016-06-24" @default.
• W2022300629 creator A5000429360 @default.
• W2022300629 creator A5010473087 @default.
• W2022300629 creator A5018535962 @default.
• W2022300629 creator A5020141525 @default.
• W2022300629 creator A5027918811 @default.
• W2022300629 creator A5035015234 @default.
• W2022300629 creator A5040756721 @default.
• W2022300629 creator A5041774394 @default.
• W2022300629 creator A5046470038 @default.
• W2022300629 creator A5050340708 @default.
• W2022300629 date "2007-02-01" @default.
• W2022300629 modified "2023-10-18" @default.
• W2022300629 title "Growth hormone (GH) replacement therapy in GH deficient adults: Predictors of one-year metabolic and clinical response" @default.
• W2022300629 cites W1538300100 @default.
• W2022300629 cites W1785599859 @default.
• W2022300629 cites W1886020038 @default.
• W2022300629 cites W2035587827 @default.
• W2022300629 cites W2054229227 @default.
• W2022300629 cites W2076273192 @default.
• W2022300629 cites W2089238944 @default.
• W2022300629 cites W2102689680 @default.
• W2022300629 cites W2115652166 @default.
• W2022300629 cites W2116404316 @default.
• W2022300629 cites W2127258766 @default.
• W2022300629 cites W2135088291 @default.
• W2022300629 cites W2154774609 @default.
• W2022300629 cites W4229962053 @default.
• W2022300629 cites W4230422193 @default.
• W2022300629 cites W4232243161 @default.
• W2022300629 cites W4235741378 @default.
• W2022300629 cites W4238620164 @default.
• W2022300629 cites W4243903367 @default.
• W2022300629 cites W4248240844 @default.
• W2022300629 cites W4250556552 @default.
• W2022300629 cites W4251027187 @default.
• W2022300629 cites W4251818304 @default.
• W2022300629 cites W4256054534 @default.
• W2022300629 cites W4256141595 @default.
• W2022300629 cites W4376595369 @default.
• W2022300629 doi "https://doi.org/10.1016/j.ghir.2006.11.002" @default.
• W2022300629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17223598" @default.
• W2022300629 hasPublicationYear "2007" @default.
• W2022300629 type Work @default.
• W2022300629 sameAs 2022300629 @default.
• W2022300629 citedByCount "29" @default.
• W2022300629 countsByYear W20223006292012 @default.
• W2022300629 countsByYear W20223006292013 @default.
• W2022300629 countsByYear W20223006292014 @default.
• W2022300629 countsByYear W20223006292015 @default.
• W2022300629 countsByYear W20223006292017 @default.
• W2022300629 countsByYear W20223006292018 @default.
• W2022300629 countsByYear W20223006292019 @default.
• W2022300629 countsByYear W20223006292021 @default.
• W2022300629 countsByYear W20223006292023 @default.
• W2022300629 crossrefType "journal-article" @default.
• W2022300629 hasAuthorship W2022300629A5000429360 @default.
• W2022300629 hasAuthorship W2022300629A5010473087 @default.
• W2022300629 hasAuthorship W2022300629A5018535962 @default.
• W2022300629 hasAuthorship W2022300629A5020141525 @default.
• W2022300629 hasAuthorship W2022300629A5027918811 @default.
• W2022300629 hasAuthorship W2022300629A5035015234 @default.
• W2022300629 hasAuthorship W2022300629A5040756721 @default.
• W2022300629 hasAuthorship W2022300629A5041774394 @default.
• W2022300629 hasAuthorship W2022300629A5046470038 @default.
• W2022300629 hasAuthorship W2022300629A5050340708 @default.
• W2022300629 hasConcept C126322002 @default.
• W2022300629 hasConcept C134018914 @default.
• W2022300629 hasConcept C2776193436 @default.
• W2022300629 hasConcept C2778491484 @default.
• W2022300629 hasConcept C2779952775 @default.
• W2022300629 hasConcept C2984496839 @default.
• W2022300629 hasConcept C511355011 @default.
• W2022300629 hasConcept C71315377 @default.
• W2022300629 hasConcept C71924100 @default.
• W2022300629 hasConceptScore W2022300629C126322002 @default.
• W2022300629 hasConceptScore W2022300629C134018914 @default.
• W2022300629 hasConceptScore W2022300629C2776193436 @default.
• W2022300629 hasConceptScore W2022300629C2778491484 @default.
• W2022300629 hasConceptScore W2022300629C2779952775 @default.
• W2022300629 hasConceptScore W2022300629C2984496839 @default.
• W2022300629 hasConceptScore W2022300629C511355011 @default.
• W2022300629 hasConceptScore W2022300629C71315377 @default.
• W2022300629 hasConceptScore W2022300629C71924100 @default.
• W2022300629 hasIssue "1" @default.
• W2022300629 hasLocation W20223006291 @default.
• W2022300629 hasLocation W20223006292 @default.
• W2022300629 hasOpenAccess W2022300629 @default.
• W2022300629 hasPrimaryLocation W20223006291 @default.
• W2022300629 hasRelatedWork W1974939875 @default.
• W2022300629 hasRelatedWork W1982197179 @default.
• W2022300629 hasRelatedWork W2005007743 @default.
• W2022300629 hasRelatedWork W2010098160 @default.
• W2022300629 hasRelatedWork W2039833188 @default.
• W2022300629 hasRelatedWork W2052457305 @default.
• W2022300629 hasRelatedWork W2068964179 @default.
• W2022300629 hasRelatedWork W2078303268 @default.

• next